Sarlósejtes vérszegénység: vizsgálatok itt: Nigéria
9 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- No phaseTaking peoplemAnaging siCkle CELl disEase Through incReased AdopTion of hydroxyurEa in Nigeria
- Where
- Abuja
- Életkor
- 12 hónap and over
- People
- 900
- Run by
- New York University
See details and how to joinNCT06318143 - No phaseTaking peopleHydroxyurea Optimisation in Sickle Cell Disease
- Where
- Ile-Ife
- Életkor
- 18 év and over
- People
- 100
- Run by
- Ochuko Orherhe
See details and how to joinNCT07543289 - 2. fázisTaking peopleA Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease
- Where
- Ituku-Ozalla, Lagos, Tarauni
- Életkor
- 6 hónap to 18 év
- People
- 95 worldwide
- Run by
- Forma Therapeutics, Inc.
See details and how to joinNCT06198712 · EU 2024-519881-32-00 - 3. fázisNot yet taking people in NigériaA Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
- Where
- Abuja, Ibadan, Ituku-Ozalla, Kaduna, Kano, Lagos
- Életkor
- 2 év and over
- People
- 480 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06609226 · EU 2024-510805-27-00 - 3. fázisNot yet taking people in NigériaA Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Where
- Abuja, Ibadan, Ituku-Ozalla, Lagos
- Életkor
- 12 év and over
- People
- 510 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06612268 · EU 2023-509175-16-00 - 2. fázisTaking peopleA Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke
- Where
- Ibadan, Lagos, Tarauni
- Életkor
- 12 év to 16 év
- People
- 27 worldwide
- Run by
- Forma Therapeutics, Inc.
See details and how to joinNCT05953584 - 2/3. fázisBefejeződöttA Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
- Where
- Ibadan, Kano, Lagos
- Életkor
- 12 év to 64 év
- People
- 389 worldwide
- Run by
- Pfizer
See details and how to joinNCT05431088 · EU 2023-508766-14-00 - 4. fázisTaking peopleStroke Prevention in Nigeria 2 Trial
- Where
- Kano
- Életkor
- 5 év to 12 év
- People
- 220
- Run by
- Vanderbilt University Medical Center
See details and how to joinNCT06526117 - No phaseTaking peopleStudy of the Role of Genetic Modifiers in Hemoglobinopathies
- Where
- Abuja, Kaduna, Zaria
- Életkor
- 2 év and over
- People
- 30 000 worldwide
- Run by
- Cyprus Institute of Neurology and Genetics
See details and how to joinNCT05799118